申请人:Novartis AG
                            
                            
                                公开号:US11072610B2
                            
                            
                                公开(公告)日:2021-07-27
                            
                            
The invention provides compounds of Formula (I)
as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
                            本发明提供了式 (I) 的化合物
和药学上可接受的盐、含有此类化合物的药物组合物,以及使用这些化合物、盐和组合物治疗病毒感染,特别是由疱疹病毒引起的感染的方法。